Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 Per Share
-
Shares outstanding
-
2,139,852
-
Total 13F shares
-
541,295
-
Share change
-
+541,295
-
Total reported value
-
$4,239,000
-
Price per share
-
$7.83
-
Number of holders
-
9
-
Value change
-
+$4,239,000
-
Number of buys
-
9
Institutional Holders of Indaptus Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (INDP) as of Q3 2021
As of 30 Sep 2021,
Indaptus Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (INDP) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
541,295 shares.
The largest 9 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, INVESTMENT HOUSE LLC, CITADEL ADVISORS LLC, MARSHALL WACE, LLP, Harel Insurance Investments & Financial Services Ltd., MORGAN STANLEY, and UBS Group AG.
This page lists
9
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.